| Infertility |
2016-003993-42: Clinical study to investigate the effectiveness and safety of PKB171 in couples with infertility due to reduced sperm mobility who wish to conceive. Ensayo clínico para investigar la eficacia y la seguridad de PKB171 en parejas con infertilidad debido a una reducción en la mobilidad del esperma, que desean concebir. |
|
|
| Ongoing | 2 | 72 | Europe | Gel PKB171, Vaginal gel | Prokrea BCN S.L., Prokrea BCN S.L. | Asthenozoospermia Astenozoospermia, Infertility due to reduced sperm mobility. Infertilidad debida a movilidad reducida del esperma., Diseases [C] - Male diseases of the urinary and reproductive systems [C12] | | | | |
2016-002385-31: Treatment of abnormal vaginal flora in patients attending in vitro fertilization treatment |
|
|
| Ongoing | 2 | 333 | Europe | Clindamycin "Alternova", Lactin-V, 37826, Capsule, hard, Vaginal delivery system, Clindamycin "Alternova" | Professor Peter Humaidan, The Fertility Clinic Skive, Statens Serum Institut, Aarhus University, Osel. inc | Infertility, infertile women attending in vitro fertilization treatment, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
| Not yet recruiting | 2 | 282 | Europe | Denosumab, Solution for injection, Prolia (Denosumab) | Dept. of Growth and Reproduction, BioInnation Institute, Rigshospitalet, Vaekstfonden, Novo Nordisk Fonden, Forskningsraadet for sundhed og sygdom | Male infertility, Poor semen quality, Diseases [C] - Male diseases of the urinary and reproductive systems [C12] | | | | |
2021-004254-37: A trial to compare efficacy and safety of follitropin delta versus placebo (inactive treatment) in the treatment of men with idiopathic infertility (unexplained reduction of semen quality). |
|
|
| Ongoing | 2 | 400 | Europe | Solution for injection in pre-filled pen, REKOVELLE | Ferring Pharmaceuticals A/S, Ferring Pharmaceuticals A/S | Idiopathic male infertility (including oligoasthenozoospermia), Unexplained reduction of semen quality in men, Diseases [C] - Male diseases of the urinary and reproductive systems [C12] | | | | |
2022-000753-80: Clinical research study to learn about the effect and safety of different doses of FE 999302 when given as a single dose for final development of the eggs after ovarian stimulation Estudio de investigación clínica para conocer el efecto y la seguridad de diferentes dosis de FE 999302 cuando se administra como dosis única para el desarrollo final de los óvulos después de la estimulación ovárica |
|
|
| Ongoing | 2 | 500 | Europe | NOVAREL, OVITRELLE, FE 999302, FE 999086, Solution for injection, Powder and solvent for solution for injection, Solution for injection in pre-filled pen, Solution for injection in pre-filled syringe, NOVAREL, OVITRELLE | Ferring Pharmaceuticals A/S, Ferring Pharmaceuticals A(S | Infertility Infertilidad, Infertility Infertilidad, Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
| Completed | 2 | 213 | Europe | Progesterone subcutaneous, Progesterone Vaginal Product | IBSA Institut Biochimique SA | Infertility | 09/22 | 12/22 | | |
| Completed | 2 | 408 | Europe, RoW | OXO-001, Placebo | OXOLIFE | Infertility, Female, Infertility | 08/23 | 12/23 | | |
PRO_ART, NCT03727971: Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study. |
|
|
| Active, not recruiting | 2 | 66 | Europe | Omalizumab Injection, NaCl | Rigshospitalet, Denmark, Novartis, Hvidovre University Hospital, Herlev Hospital, Zealand University Hospital | Asthma, Infertility, Female | 12/23 | 12/29 | | |
NCT05403476: A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM) |
|
|
| Recruiting | 2 | 400 | Europe, US | FE 999049, REKOVELLE, Follitropin Delta, Placebo | Ferring Pharmaceuticals | Male Idiopathic Infertility | 07/26 | 07/26 | | |
NCT05279768: Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance. |
|
|
| Recruiting | 1/2 | 40 | RoW | UC-MSCs, Secretomes, UC-MSCs and Secretomes, Control | PT. Prodia Stem Cell Indonesia | Polycystic Ovary Syndrome | 12/23 | 12/23 | | |
